Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 20 Nov 2026, 03:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+395%
- Median
- +27.7%
- Combined market value
- PLN 15.11T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | PLN 20.2B | PLN 57.51 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | PLN 37.5B | PLN 394.82 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | PLN 26.8B | PLN 394.57 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | PLN 21.2B | PLN 503.03 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | PLN 16.3B | PLN 119.22 | 1.24% up | 168% up | ||
| 6 | TG TherapeuticsTGTX · Health Care | +117% | PLN 39.7B | PLN 262.37 | 1.88% down | 117% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +108% | PLN 19.3B | PLN 343.05 | 1.01% up | 108% up | ||
| 8 | ViatrisVTRS · Health Care | +99.0% | PLN 92.2B | PLN 80.39 | 1.97% down | 99% up | ||
| 9 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | PLN 30.1B | PLN 86.50 | 2.24% down | 90% up | ||
| 10 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | PLN 35.1B | PLN 1,257.28 | 1.87% up | 86% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | PLN 18.2B | PLN 166.49 | 0.48% down | 86% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +78.9% | PLN 157.5B | PLN 273.86 | 1.38% down | 79% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | PLN 32.7B | PLN 501.54 | 2.47% down | 51% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | PLN 23.2B | PLN 1,160.39 | 3.94% down | 50% up | ||
| 15 | Merck & CoMRK · Health Care | +45.1% | PLN 1.32T | PLN 537.08 | 3.61% down | 45% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | +44.7% | PLN 18.7B | PLN 195.33 | 3.86% down | 45% up | ||
| 17 | Belite BioBLTE · Health Care | +43.1% | PLN 24.8B | PLN 610.72 | 3.33% down | 43% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +34.3% | PLN 2.6T | PLN 1,080.31 | 2.04% down | 34% up | ||
| 19 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | PLN 25.2B | PLN 386.24 | 3.27% up | 34% up | ||
| 20 | Eli LillyLLY · Health Care | +32.5% | PLN 4.87T | PLN 5,463.93 | 2.29% down | 33% up | ||
| 21 | Bristol-Myers SquibbBMY · Health Care | +29.6% | PLN 482.3B | PLN 235.93 | 2.05% down | 30% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | PLN 386.3B | PLN 3,733.99 | 2.35% down | 28% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | PLN 533.8B | PLN 2,105.55 | 2.94% down | 27% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | +25.7% | PLN 53.1B | PLN 106.32 | 1.54% down | 26% up | ||
| 25 | AbbVieABBV · Health Care | +24.7% | PLN 2.03T | PLN 1,146.64 | 0.86% down | 25% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +21.6% | PLN 96.3B | PLN 2,261.00 | 3.16% down | 22% up | ||
| 27 | BridgeBio PharmaBBIO · Health Care | +20.7% | PLN 61.6B | PLN 316.16 | 0.22% up | 21% up | ||
| 28 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | PLN 32.7B | PLN 472.34 | 1.88% down | 18% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | PLN 48.1B | PLN 248.38 | 0.02% down | 17% up | ||
| 30 | PfizerPFE · Health Care | +15.0% | PLN 634.8B | PLN 111.37 | 1.85% down | 15% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | PLN 25B | PLN 176.52 | 1.25% up | 13% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -6.50% | PLN 28.9B | PLN 548.69 | 1.25% up | 6% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -9.67% | PLN 28.8B | PLN 262.78 | 4.15% down | 10% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -15.7% | PLN 727.5B | PLN 420.05 | 0.58% down | 16% down | ||
| 35 | CytokineticsCYTK · Health Care | -19.2% | PLN 29B | PLN 208.10 | 0.27% up | 19% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -19.9% | PLN 19.5B | PLN 112.18 | 0.25% down | 20% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -21.2% | PLN 19.7B | PLN 235.87 | 3.16% down | 21% down | ||
| 38 | ZoetisZTS · Health Care | -26.2% | PLN 132.7B | PLN 326.71 | 5.59% down | 26% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | PLN 37.3B | PLN 1,604.42 | 0.34% down | 27% down | ||
| 40 | Summit TherapeuticsSMMT · Health Care | -36.2% | PLN 34.2B | PLN 42.75 | 0.67% up | 36% down | ||
| 41 | InsmedINSM · Health Care | -40.0% | PLN 128.2B | PLN 584.20 | 20.58% up | 40% down | ||
| 42 | Legend BiotechLEGN · Health Care | -41.0% | PLN 12.6B | PLN 65.11 | 0.92% down | 41% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | PLN 18.3B | PLN 110.08 | 0.62% down | 63% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | PLN 80.1B | PLN 597.78 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0440 PLN).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 03:16 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of PLN 15.11T as of 20 Nov 2026, 03:16 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.